Novartis Highlights New Findings in Advancing Care for Patients With 170

Novartis highlights new findings in advancing care for patients with 170
If patients experience these side effects, they may need to stop taking Afinitor or Afinitor Disperz for a while or use a lower dose. Patients …. drugs (including, but not limited to, amiodarone, disopyramide, procainamide, quinidine, and sotalol …
Read more on FierceBiotech

Comments are closed.